EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of metformin on inflammation and bone damage in a rat model of medication‐related osteonecrosis of the jaw

Liviane Maria Alves Rabelo iD, Mariana Vasconcelos Guimarães iD, Aurilene Gomes Cajado iD, José Vitor Mota Lemos iD, Felipe Domingos de Sousa iD, Nylane Maria Nunes Alencar iD, Vilma de Lima iD, Paulo Goberlânio de Barros Silva iD, Ana Paula Negreiros Nunes Alves iD, Deysi Viviana Tenazoa Wong iD, Roberto César Pereira Lima-Júnior iD

European Journal of Oral Sciences · 2026

DOI: 10.1111/eos.70056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Oral Sciences, 2026. Verfasst von Liviane Maria Alves Rabelo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. Hauptthemen laut MEDLINE: Metformin, Bisphosphonate-Associated Osteonecrosis of the Jaw, Inflammation. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), FUNCAP (Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated how chronic metformin administration modulates the cellular profile and inflammatory markers in a zoledronic acid‐based rat model of medication‐related osteonecrosis of the jaw (MRONJ). Male Wistar rats were allocated to different treatments: (i) naïve, (ii) MRONJ (zoledronic acid, 0.2 mg/kg, i.v. on days 0, 7, 14, and 49), or (iii) MRONJ + metformin (250 mg/kg, by gavage, daily for 70 days). All rats had the inferior first molar extracted on day 42. Mandibular arches were harvested for analyzing their gums on day 70. Additionally, RAW 264.7 cells were incubated with zoledronic acid or metformin for cell viability tests and analysis of interleukin‐1β (IL‐1β) production. MRONJ was characterized by increased numbers of empty osteocyte lacunae, osteoclasts, and apoptotic osteoclasts, and by high expression of tartrate‐resistant acid phosphatase (TRAP) and F4/80 (a macrophage marker). Zoledronic acid‐incubated RAW 264.7 macrophages showed increased IL‐1β expression. Metformin reduced the number of empty bone lacunae, apoptotic osteoclasts, leukocyte infiltrate, and F4/80 positive cells in the alveolar bone. It increased TRAP expression levels without altering the number of osteoclasts. Metformin also reduced the myeloperoxidase activity and decreased IL‐1β levels in vitro. In conclusion, metformin reduced the severity of MRONJ by mitigating the inflammatory response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminBisphosphonate-Associated Osteonecrosis of the JawInflammationAnimalsZoledronic AcidMaleRats, WistarRatsInterleukin-1betaMiceDisease Models, AnimalRAW 264.7 CellsOsteoclastsDiphosphonatesTartrate-Resistant Acid PhosphataseApoptosisImidazolesBone Density Conservation AgentsCell Survival

Stichwörter der Autor:innen

bone healingcell viabilityinterleukin‐1βmacrophagezoledronic acid

Substanzen

MetforminZoledronic AcidInterleukin-1betaDiphosphonatesTartrate-Resistant Acid PhosphataseImidazolesBone Density Conservation Agents

Autor:innen und Institutionen

  • Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil.
  • Department of Dental Clinic, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Brazil.
  • Northeast Network of Biotechnology (RENORBIO), Centre for Experimental Biology (Nubex), University of Fortaleza (UNIFOR), Fortaleza, Brazil.

ORCID-Profile: Liviane Maria Alves Rabelo, Mariana Vasconcelos Guimarães, Aurilene Gomes Cajado, José Vitor Mota Lemos, Felipe Domingos de Sousa, Nylane Maria Nunes Alencar, Vilma de Lima, Paulo Goberlânio de Barros Silva, Ana Paula Negreiros Nunes Alves, Deysi Viviana Tenazoa Wong, Roberto César Pereira Lima-Júnior

Förderung

  • CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico)
  • CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior)
  • FUNCAP (Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico)
  • Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico

Zitieren

APA

Rabelo, L. M. A., Guimarães, M. V., Cajado, A. G., Lemos, J. V. M., de Sousa, F. D., Alencar, N. M. N., de Lima, V., de Barros Silva, P. G., Alves, A. P. N. N., Wong, D. V. T., & Lima-Júnior, R. C. P. (2026). Effect of metformin on inflammation and bone damage in a rat model of medication‐related osteonecrosis of the jaw. European Journal of Oral Sciences. https://doi.org/10.1111/eos.70056

Vancouver

Rabelo LMA, Guimarães MV, Cajado AG, Lemos JVM, de Sousa FD, Alencar NMN, et al. Effect of metformin on inflammation and bone damage in a rat model of medication‐related osteonecrosis of the jaw. European Journal of Oral Sciences. 2026. doi:10.1111/eos.70056

BibTeX
@article{Rabelo2026,
  author = {Rabelo, Liviane Maria Alves and Guimarães, Mariana Vasconcelos and Cajado, Aurilene Gomes and Lemos, José Vitor Mota and de Sousa, Felipe Domingos and Alencar, Nylane Maria Nunes and de Lima, Vilma and de Barros Silva, Paulo Goberlânio and Alves, Ana Paula Negreiros Nunes and Wong, Deysi Viviana Tenazoa and Lima-Júnior, Roberto César Pereira},
  title = {Effect of metformin on inflammation and bone damage in a rat model of medication‐related osteonecrosis of the jaw},
  journal = {European Journal of Oral Sciences},
  year = {2026},
  doi = {10.1111/eos.70056}
}
Kostenlos starten →